Previous studies have demonstrated that elevated serum levels of TARC and MDC correlate with skin disease severity in AD patients [34], and expression of TARC and MDC is increased in the lesional skin of AD patients [35]. This evidence concerns the gene CCL17 and Alzheimer disease.